Maitland-van der Zee, Anke-Hilse <br/><br/>
Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).  [electronic resource] 

 -  Acta cardiologica  Jun 2006 
 - 327-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0001-5385 
<br/><br/><label>Standard No.: </label>10.2143/AC.61.3.2014836  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticholesteremic Agents--therapeutic use<br/>Apolipoprotein E2--genetics<br/>Apolipoprotein E3--genetics<br/>Apolipoprotein E4--genetics<br/>Apolipoproteins E--genetics<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Coronary Artery Disease--blood<br/>Genetic Carrier Screening<br/>Genetic Predisposition to Disease--genetics<br/>Genotype<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Male<br/>Middle Aged<br/>Polymorphism, Genetic--genetics<br/>Pravastatin--therapeutic use<br/>Regression Analysis<br/>Statistics as Topic<br/>Treatment Outcome<br/>Triglycerides--blood